Accueil › Cancer du sein › Californie › San Diego
Essais cliniques pour Cancer du sein à San Diego, CA
41 études pour Cancer du sein recherchent des participants dans et autour de San Diego (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Recrutement en coursPhase 3
- University of California San Diego Moores Cancer Center, San Diego
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- University of San Diego Moores Cancer Center, La Jolla · à 11 mi
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Recrutement en coursPhase 3
- Sharp Rees Stealy Medical Group Inc, San Diego
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Recrutement en coursPhase 1
- University of California San Diego Moores Cancer Center, San Diego
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Recrutement en coursPhase 1/2
- Sharp Memorial Hospital, San Diego
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Recrutement en coursPhase 2
- California Protons Cancer Therapy Center, San Diego
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Recrutement en coursPhase 3
- California Protons Cancer Therapy Center, San Diego
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Recrutement en coursPhase 2
- UC San Diego Moores Cancer Center, La Jolla · à 11 mi
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Recrutement en coursPhase 3
- Clinical Trial Site, La Jolla · à 11 mi
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Recrutement en coursPhase 3
- Moores Cancer Center, La Jolla · à 11 mi
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Recrutement en coursVolontaires sains bienvenus
- University of California San Diego, San Diego
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Recrutement en coursPhase 3
- University Of California - San Diego Moores Cancer Center, La Jolla · à 11 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Recrutement en coursPhase 3
- UC San Diego Moores Cancer Center, La Jolla · à 11 mi
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Recrutement en coursPhase 1/2
- University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla, La Jolla · à 11 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recrutement en coursPhase 1
- Scripps Health, San Diego
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recrutement en coursPhase 1
- UCSD Moores Cancer Center, La Jolla · à 11 mi
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Recrutement en coursPhase 1/2
- University of California San Diego Medical Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · à 11 mi
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Recrutement en coursPhase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · à 11 mi
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Recrutement en coursPhase 1/2
- University of California-San Diego, La Jolla · à 11 mi
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Recrutement en coursPhase 3
- Scripps Health, La Jolla · à 11 mi
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Recrutement en coursPhase 3
- UC San Diego, San Diego
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- UC San Diego Moores Cancer Center, La Jolla · à 11 mi
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Recrutement en coursÉtude observationnelle
- University of California, San Diego, San Diego
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Recrutement en coursPhase 3
- Kaiser Permanente-Rio San Diego, San Diego
- Kaiser Permanente-San Diego Zion, San Diego
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
Recrutement en coursVolontaires sains bienvenus
- University of California, San Diego, La Jolla · à 11 mi
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- UC San Diego Moores Cancer Center, La Jolla · à 11 mi
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Recrutement en coursPhase 2
- Scripps Health, San Diego
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Recrutement en coursPhase 3
- UC San Diego Medical Center - Hillcrest, San Diego
- California Protons Cancer Therapy Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · à 11 mi
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Recrutement en coursPhase 1
- University of California, San Diego, La Jolla · à 11 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Recrutement en coursPhase 3
- University of California San Diego - Moores Cancer Center, La Jolla · à 11 mi
E-Mindfulness Approaches for Living After Breast Cancer
Recrutement en coursPhase 3
- Kaiser Permanente-San Diego Zion, San Diego
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recrutement en coursPhase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Investigative Site #101, La Jolla · à 11 mi
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Recrutement en coursPhase 2
- University of California San Diego, La Jolla · à 11 mi
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Recrutement en coursPhase 1/2
- SHARP Healthcare, San Diego
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
Recrutement en coursPhase 2
- University of California, San Diego, La Jolla · à 11 mi
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Recrutement en coursPhase 1/2
- Research Site, La Jolla · à 11 mi
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Recrutement en cours
- UC San Diego Health, La Jolla · à 11 mi
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
Recrutement en cours
- University of California, San Diego, La Jolla · à 11 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, La Jolla · à 11 mi
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Recrutement en coursPhase 1
- University of California-San Diego, San Diego
Essais pour Cancer du sein dans d'autres villes
- New York City, NY136 études
- Houston, TX126 études
- Boston, MA112 études
- Nashville, TN81 études
- Los Angeles, CA73 études
- Edison, NJ68 études
- St. Louis, MO64 études
- Queens, NY64 études
- Durham, NC64 études
- Chicago, IL59 études
- Philadelphia, PA56 études
- Dallas, TX55 études
Autres études à San Diego
- Cancer du poumon non à petites cellules48 études
- Cancer (tous types)32 études
- Cancer de la prostate31 études
- Cancer métastatique30 études
- Cancer colorectal25 études
- Cancer de l'ovaire24 études
- Cancer du pancréas24 études
- Cancer du poumon23 études
- Obésité23 études
- Insuffisance cardiaque23 études
- Dépression21 études
- Mélanome18 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.